Windlas Biotech Schedules Investor Meetings on September 7, 2026
Windlas Biotech will hold virtual investor and analyst meetings on September 7, 2026. Meetings include one-on-one sessions with ICICI Direct, Bajaj Broking, and Haitong Securities, alongside a group investor meeting. Discussions will be based on publicly available information only.
This is a standard disclosure regarding investor engagement. It does not involve any new business developments, financial results, or strategic decisions that would significantly impact the company's stock or operations.
The announcement is a routine intimation of upcoming investor meetings and does not contain any new financial or business performance information that would suggest a positive or negative sentiment.
Windlas Biotech Limited has announced a series of meetings with investors and analysts scheduled for Monday, September 7, 2026. The company officials will engage in one-on-one virtual meetings with ICICI Direct at 2:00 PM, Bajaj Broking at 3:00 PM, and Haitong Securities at 5:00 PM. Additionally, a group meeting with investors is scheduled for 4:00 PM.
During these interactions, Windlas Biotech will refer exclusively to publicly available documents. The company has assured that no unpublished price-sensitive information (UPSI) will be shared. The schedule is subject to potential changes based on the exigencies of the investors, analysts, or the company.
This engagement is being conducted in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A plain-language summary of a public exchange filing by Windlas Biotech Limited. Read the original for the full detail.